NKTRs: Immune System Targets for Cancer and Neurodegenerative Diseases

Target Name: Natural cytotoxicity triggering Receptor

NCBI ID: P47701

Natural cytotoxicity triggering Receptor

Other Name(s): NKTR

NKTRs: Immune System Targets for Cancer and Neurodegenerative Diseases

Natural cytotoxicity triggering receptor (NKTR) is a protein that plays a crucial role in the immune system. It is a subtype of NK receptor, which is a family of cytotoxic T-cell receptors that can recognize and destroy infected or abnormal cells. NKTRs are involved in the regulation of cell death, and their dysfunction has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

NKTRs are composed of a constant region and an variable region that contains the NK receptor signature. The constant region consists of a nucleotide acid that is highly conserved across different species, while the variable region is responsible for the recognition of specific cytotoxic molecules. NKTRs can recognize a wide variety of cytotoxic molecules, including DNA, RNA, protein, and lipids.

NKTRs are involved in the immune response by providing an adaptive response to cytotoxic threats. During the cell division, NKTRs help to detect and destroy cells that have undergone genetic changes or are damaged. They also play a role in regulating the balance between cell proliferation and cell death, ensuring that the immune system does not become too aggressive or destructive.

One of the unique features of NKTRs is their ability to induce cell death, also known as apoptosis. NKTRs recognize their target cells, which is usually infected or damaged, and then induce them to undergo apoptosis. This process is regulated by a variety of factors , including the concentration of cytotoxic molecules, the signaling pathways involved, and the cell type being targeted.

The NKTRs are also involved in the regulation of inflammation. When the body is exposed to an invading agent, NKTRs help to control the response of the immune system. They can modulate the production of pro-inflammatory cytokines, such as TNF-alpha and IL -12, and can also influence the production of anti-inflammatory cytokines, such as IL-10.

NKTRs have also been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, NKTR dysfunction has been implicated in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. It has also been associated with the development of certain cancers, such as lung and ovarian cancer.

In addition to its role in the immune system and disease, NKTRs are also a drug target. Researchers have identified a number of small molecules that can modulate NKTR function, and these molecules have been used to develop new treatments for a variety of diseases. For For example, inhibitors of the NKTRs have been shown to be effective in treating certain types of cancer, and autoimmune diseases.

In conclusion, Natural cytotoxicity triggering receptor (NKTR) is a protein that plays a crucial role in the immune system. Its ability to recognize and destroy damaged cells makes it an attractive drug target for the development of new treatments for a variety of diseases. The Regulation of cell death by NKTRs is a complex process that is influenced by a variety of factors, including the concentration of cytotoxic molecules, the signaling pathways involved, and the cell type being targeted. Further research is needed to fully understand the role of NKTRs in the immune system and their potential as drug targets.

Protein Name: Natural Cytotoxicity Triggering Receptor (nonspecified Subtype)

The "Natural cytotoxicity triggering Receptor Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Natural cytotoxicity triggering Receptor comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets